Holder snapshot 7 signals
Share change
+2,075,787
Put/Call ratio
25%
SEC-reported price per share
$1.09
Number of holders
62
Value change
+$2,091,094
Number of buys
22
Open additional details 1 more signal available
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,571,428,571

Security key

00653A107

Report period

Q1 2023

Institutions

62

Top holders

10

Ownership snapshot

Top reported holders of ADAPY - Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F Lead comparable stake: 2.5% Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP leads the comparable SEC ownership view at 2.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership Top 5
Matrix Capital Management Company... 2.5%
BAILLIE GIFFORD & CO 1.1%
NEA Management Company, LLC 1.1%
BAKER BROS. ADVISORS LP 0.63%
Long Focus Capital Management, LLC 0.34%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Matrix Capital Management Company, LP
13F
Company
13F
2.5%
$56,902,310
38,974,185 shares
31 Dec 2022
BAILLIE GIFFORD & CO
13F
Company
13F
1.1%
$25,068,111
17,169,939 shares
31 Dec 2022
NEA Management Company, LLC
13F
Company
13F
1.1%
$24,936,476
17,079,779 shares
31 Dec 2022
BAKER BROS. ADVISORS LP
13F
Company
13F
0.63%
$14,353,080
9,830,877 shares
31 Dec 2022
Long Focus Capital Management, LLC
13F
Company
13F
0.34%
$7,714,113
5,283,639 shares
31 Dec 2022
PFM Health Sciences, LP
13F
Company
13F
0.31%
$7,071,525
4,843,510 shares
31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
62
Shares
115,955,853
Rows available
62
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
62
Q1 2023 holders
62
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .